BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
CorVel
CRVL
$3.32B
| $55K | ﹤0.01% |
2,328
-8,937
| -79% | -$176K |
|
2852
Dine Brands
DIN
$447M
| $54.9K | ﹤0.01% |
1,304
-5,494
| -81% | -$222K |
|
2853
Oceaneering
OII
$5.2B
| $54.7K | ﹤0.01% |
8,557
-243,257
| -97% | -$1.28M |
|
|
HTLF
2854
DELISTED
Heartland Financial USA, Inc.
HTLF
| $54.6K | ﹤0.01% |
1,634
-10,130
| -86% | -$317K |
|
2855
Lantheus
LNTH
$6.59B
| $54.5K | ﹤0.01% |
3,813
-11,646
| -75% | -$154K |
|
2856
Marcus & Millichap
MMI
$1.2B
| $54.5K | ﹤0.01% |
1,887
-7,834
| -81% | -$221K |
|
|
SPPI
2857
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $54.4K | ﹤0.01% |
16,095
-48,998
| -75% | -$143K |
|
2858
Southside Bancshares
SBSI
$986M
| $54.4K | ﹤0.01% |
1,962
-10,797
| -85% | -$307K |
|
2859
Chesapeake Utilities
CPK
$3.26B
| $54.3K | ﹤0.01% |
646
-4,300
| -87% | -$374K |
|
2860
BlueLinx
BXC
$680M
| $53.9K | ﹤0.01% |
6,287
+3,505
| +126% | +$21.6K |
|
2861
Flexsteel Industries
FLXS
$301M
| $53.8K | ﹤0.01% |
4,257
+1,949
| +84% | +$19.5K |
|
|
NTUS
2862
DELISTED
Natus Medical Inc
NTUS
| $53.7K | ﹤0.01% |
2,460
-11,402
| -82% | -$261K |
|
2863
Trupanion
TRUP
$1.34B
| $53.7K | ﹤0.01% |
1,257
-7,666
| -86% | -$248K |
|
2864
Inogen
INGN
$153M
| $53.6K | ﹤0.01% |
1,508
-6,216
| -80% | -$262K |
|
2865
Axcelis
ACLS
$4.33B
| $53.1K | ﹤0.01% |
1,905
-10,999
| -85% | -$268K |
|
|
PTR
2866
CALL
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $52.9K | ﹤0.01% |
16
-225
| -93% | -$7.94K |
|
|
NVO
2867
Novo Nordisk
NVO
$201B
| $52.8K | ﹤0.01% |
1,614
-17,186
| -91% | -$548K |
|
2868
Assembly Biosciences
ASMB
$653M
| $52.8K | ﹤0.01% |
189
-529
| -74% | -$123K |
|
2869
Veeco
VECO
$3.2B
| $52.7K | ﹤0.01% |
3,910
-195,678
| -98% | -$2.25M |
|
|
MNR
2870
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $52.7K | ﹤0.01% |
3,640
-37,186
| -91% | -$483K |
|
|
OSG
2871
Octave Specialty Group
OSG
$221M
| $52.5K | ﹤0.01% |
3,669
-15,150
| -81% | -$221K |
|
2872
Nelnet
NNI
$4.57B
| $52.5K | ﹤0.01% |
1,100
-4,890
| -82% | -$229K |
|
|
CEO
2873
DELISTED
CNOOC Limited
CEO
| $52.4K | ﹤0.01% |
464
-11,632
| -96% | -$1.31M |
|
2874
Mesa Laboratories
MLAB
$593M
| $52K | ﹤0.01% |
240
-1,355
| -85% | -$312K |
|
2875
SEACOR Marine Holdings
SMHI
$268M
| $51.9K | ﹤0.01% |
20,369
+14,285
| +235% | +$40.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.